뒤로
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SHEZF) 가격
SHEZF 주가 차트
SHEZF 수입
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
$0.46
0%
$0
종가: Jan 27, 16:00:00 GMT-5
$0.46
0%
$0
애프터마켓: Jan 27, 20:00:00 GMT-5
Earnings FAQ
SHEZF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. SHEZF의 지난 분기 매출 실적은 어땠나요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.의 매출 추정치는 얼마인가요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.의 수익 품질 점수는 얼마인가요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.는 언제 수익을 보고하나요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.의 예상 수익은 얼마인가요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.4696
시가
$0.7206
일일 범위
$0.4696 - $0.7206
52주 범위
$0.4696 - $0.7206
거래량
25
평균 거래량
0
EPS(TTM)
-0.02
배당수익률
--
시가총액
$103.3M
SHENZHEN HEPALINK PHARMACEUTICA란 무엇인가요?
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 1,926 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the heparin industry chain, contract development and manufacturing organization (CDMO) of biological macromolecules, and the investment, development, and commercialization of innovative drugs. The firm operates four segments. The Pharmaceutical Formulations segment manufactures and sells enoxaparin sodium injection and others. The Active Pharmaceutical Ingredients (APIs) segment manufactures and sells standard heparin APIs, enoxaparin APIs and others. The CDMO segment provides process development services for pharmaceutical intermediates and APIs, including process research, optimization, analytical testing, and formulation research. The Other segment engages in other product businesses, such as pancreatic enzymes and casings. The firm conducts its business in the domestic and overseas markets.